BMO Capital Downgrades Regeneron Pharma (REGN) to Market Perform

January 15, 2014 7:02 AM EST Send to a Friend
Get Alerts REGN Hot Sheet
Price: $402.50 +2.17%

Rating Summary:
    17 Buy, 11 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade REGN Now!
Join SI Premium – FREE
BMO Capital downgraded Regeneron Pharma (NASDAQ: REGN) from Outperform to Market Perform with a price target of $331.00 (unchanged)

For an analyst ratings summary and ratings history on Regeneron Pharma click here. For more ratings news on Regeneron Pharma click here.

Shares of Regeneron Pharma closed at $268.68 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Downgrades

Related Entities

BMO Capital

Add Your Comment